Hims & Hers Health: Don't Nickpick Quarterly Results (NYSE:HIMS)
· seekingalpha.com
Hims & Hers Health maintains robust growth prospects despite a minor Q3'26 revenue miss, leading to a market overreaction. Read more on HIMS stock here.
Hims & Hers Health, Inc. (HIMS) reported another great quarter and maintains impressive growth prospects. The market will nitpick the Q3'26 results missing cons...